Regor announced its 12-week single-dose Phase 2a trial results for RGT-075,a once-daily oral GLP-1RA,reporting 5% placebo-adjusted weight-loss with no plateau
BANGKOK,Jan. 13,2025-- Professor Dr. Wilert Puriwat,President of Chulalongkorn University,announces the findings from the "Future of Jobs 2025" report. Chulalongkorn University is the only p
MELBOURNE,Australiaand INDIANAPOLIS,Jan. 13,2025-- Telix Pharmaceuticals Limited (ASX: TLX,Nasdaq: TLX,Telix,the Company) today announces it has entered into an asset purchase agreement with antibody
LAS VEGAS,Jan. 12,2025-- At CES 2025,TESSAN showcased its relentless pursuit of technological innovation and enhanced user experience,engaging with a diverse audience to reinforce its commitment to be
SINGAPORE,Jan. 11,2025-- LANDI Global proudly announces the launch of the Cx20 terminal,our flagship next-generation smart Windows Desktop POS.
LAS VEGAS,Jan. 12,2025-- The highly anticipated 2024-2025 Global Top Brands Award Ceremony and International Consumer Electronics Industry Leaders\' Summit were held on January 8,2025 local time,at th
